User:Mr. Ibrahem/Omidenepag

Omidenepag, sold under the brand name Eybelis among others, is a medication used to treat ocular hypertension including glaucoma. It is used as an eye drop.

Common side effects include sensitivity to light, blurry vision, eye redness, headache, and eye pain. Other side effects may include changes to the eyelashes and macular edema. It is a relatively selective prostaglandin E2 (EP2) receptor activator.

Omidenepag was approved for medical use in Japan in 2018, and the United States in 2022. It is not currently in the approval process in either Europe or the United Kingdom as of 2022.